Amira Sayed Hanafy
Amira Sayed Hanafy
Senior Scientist, Department of Neurosurgery, University Hospital Bonn
Verified email at
Cited by
Cited by
Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges
MM Wen, NS El-Salamouni, WM El-Refaie, HA Hazzah, MM Ali, G Tosi, ...
Journal of Controlled Release, 2016
Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat …
AS Hanafy, RM Farid, SS ElGamal
Drug development and industrial pharmacy 41 (12), 2055-2068, 2015
Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease …
AS Hanafy, RM Farid, MW Helmy, SS ElGamal
Drug delivery 23 (8), 3111-3122, 2016
Micro-and nanotechnology approaches to improve Parkinson's disease therapy
PV Torres-Ortega, L Saludas, AS Hanafy, E Garbayo, MJ Blanco-Prieto
Journal of controlled release 295, 201-213, 2019
Thermoresponsive Hyalomer intra-articular hydrogels improve monoiodoacetate-induced osteoarthritis in rats
AS Hanafy, SO El-Ganainy
International Journal of Pharmaceutics 573, 118859, 2020
Pulsatile core-in-cup valsartan tablet formulations: in vitro evaluation
MS Sokar, AS Hanafy, AH El-Kamel, SS El-Gamal
asian journal of pharmaceutical sciences 8 (4), 234-243, 2013
Novel treatment strategies for brain tumors and metastases
SE El-Habashy, AM Nazief, CE Adkins, MM Wen, AH El-Kamel, ...
Pharmaceutical patent analyst 3 (3), 279-296, 2014
Blood-brain barrier models: Rationale for selection
AS Hanafy, D Dietrich, G Fricker, A Lamprecht
Advanced Drug Delivery Reviews 176, 113859, 2021
CRISPR/Cas9 delivery potentials in Alzheimer’s disease management: a mini review
AS Hanafy, S Schoch, A Lamprecht
Pharmaceutics 12 (9), 801, 2020
Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection potentials in rat brains via antioxidant effect
LS Kandil, RM Farid, SS ElGamal, AS Hanafy
Drug Development and Industrial Pharmacy 47 (5), 735-740, 2021
Galantamine nanoparticles outperform oral galantamine in an Alzheimer’s rat model: pharmacokinetics and pharmacodynamics
SO El-Ganainy, MA Gowayed, M Agami, P Mohamed, M Belal, RM Farid, ...
Nanomedicine 16 (15), 1281-1296, 2021
Design of chronomodulated drug delivery system of valsartan: in vitro characterization
M Sokar, A Hanafy, A Elkamel, S El-Gamal
Indian Journal of Pharmaceutical Sciences 77 (4), 470, 2015
Galantamine transdermal patch shows higher tolerability over oral galantamine in rheumatoid arthritis rat model
LS Kandil, AS Hanafy, SA Abdelhady
Drug Development and Industrial Pharmacy 46 (6), 996-1004, 2020
Subcellular analysis of blood-brain barrier function by micro-impalement of vessels in acute brain slices
AS Hanafy, P Steinlein, J Pitsch, MH Silva, N Vana, AJ Becker, ...
Nature Communications 14 (1), 481, 2023
Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers
SO El Ganainy, T Cijsouw, MA Ali, S Schoch, AS Hanafy
Expert Review of Neurotherapeutics 22 (4), 319-335, 2022
Hyaluronic-benzydamine oromucosal films outperform conventional mouth rinse in ulcer healing
NS El-Salamouni, AS Hanafy
Journal of Drug Delivery Science and Technology 65, 102690, 2021
Nanobiotechnology in parkinson’s disease
PV Torres-Ortega, I Martínez-Valbuena, G Martí-Andrés, AS Hanafy, ...
Nanobiotechnology in Neurodegenerative Diseases, 177-208, 2019
Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer’s model
AS Hanafy, A Lamprecht, D Dietrich
Fluids and Barriers of the CNS 20 (1), 85, 2023
Formulation And Evaluation Of Valsartan Pulsatile Drug Delivery Systems
AS Hanafy
The system can't perform the operation now. Try again later.
Articles 1–19